Thrombopoietin in vitro and in vivo

Cytokines, Cellular and Molecular Therapy

Volumn 4, Issue 1, 1998, Pages 25-34

  Alexander, Warren S ^a   Begley, C Glenn ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Megakaryocyte; Megakaryocyte growth and development factor; Mpl ligand; Platelet; Thrombopoietin

Indexed keywords

CELL RECEPTOR; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; RAS PROTEIN; RECOMBINANT MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; RECOMBINANT THROMBOPOIETIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; THROMBOPOIETIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; GENE TARGETING; HEMATOPOIESIS; HUMAN; MEGAKARYOCYTE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTOPENIA;

EID: 0031950562     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (118)

1. Gordon MS, Hoffman R, Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopenia. Blood (1992) 80: 302-7.
2. Keleman E, Cserhati I, Tanos B, Demonstration and some properties of human thrombopoietin in thrombocytopenic sera. Acta Haematol (1958) 20: 350-3.
3. Evatt BL, Levin J, Measurement of thrombopoiesis in rabbits using selenomethionine J Clin Invest (1969) 48: 1615-26.
4. Penington DG, Isotope bioassay for 'thrombopoietin'. Br Med J (1970) i: 606-8.
5. Long MW, Williams N, Ebbe S, Immature megakaryocytes in the mouse: physical characteristics, cell cycle status, and in vitro responsiveness to thrombopoietic stimulatory factor. Blood (1982) 59: 569-75.
6. Leven RM, Yee MK, Megakaryocyte morphogenesis stimulated in vitro by whole and partially fractionated thrombocytopenic plasma. a model system for the study of platelet formation. Blood (1987) 69: 1046-52.
7. Hill RJ, Leven RM, Levin FC, Leven J, The effect of partially purified thrombopoietin on guinea pig megakaryocyte ploidy in vitro. Exp Hematol (1989) 17: 903-7.
8. Wendling F, Varlet P, Charon M, Tambourin P, MPLV: a retrovirus complex inducing an acute myeloproliferative leukemic disorder in adult mice. Virology (1986) 149: 242-6.
9. Wendling F, Penciolelli J-F, Charon M, Tambourin P, Factor-independent erythropoietic progenitor cells in leukemia induced by the myeloproliferative leukemia virus. Blood (1989) 73: 1161-7.
10. Wendling F, Vigon I, Souyri M, Tambourin P, Myeloid progenitor cells transformed by the myeloproliferative leukemia virus proliferate and differentiate in vitro without the addition of growth factors. Leukemia (1989) 3: 475-80.
11. Souyri M, Vigon I, Penciolelli J-F et al, A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell (1990) 63: 1137-4-7.
12. Methia N, Louache F, Vainchenker W, Wendling F, Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood (1993) 82: 1395-401.
13. Bartley TD, Bogenberger J, Hunt P et al, Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell (1994) 77: 1117-24.
14. DeSauvage FJ, Hass PE, Spencer SD et al, Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature (1994) 369: 533-8.
15. Lok S, Kaushansky K, Holly RD et al, Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature (1994) 369: 565-8.
16. Sohma Y, Akahori H, Seki N et al, Molecular cloning and chromosomal localisation of the human thrombopoietin gene. FEBS Lett (1994) 353: 57-61.
17. Foster DC, Sprecher CA, Grant FJ et al, Human thrombopoietin gene structure, cDNA sequence, expression and chromosomal localization. Proc Natl Acad Sci USA (1994) 91: 13 023-7.
18. Chang M-S, Hsu R-Y, McNinch J et al, The gene for murine megakaryocyte growth and development factor (thrombopoietin, Thpo) is located on mouse chromosome 16. Genomics (1995) 26: 636-7.
19. McCarty JM, Sprugel KH, Fox NE et al, Murine thrombopoietin mRNA levels are modulated by platelet count. Blood (1995) 86: 3668-75.
20. Stoffel R, Wiestner A, Skoda RC, Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets Blood (1996) 87: 567-73.
21. Sungaran R, Markovic B, Chong BH, Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood (1996) 89: 101-7.
22. Nagahisa H, Nagata Y, Ohnuki T et al, Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation. Blood (1996) 87: 1309-16.
23. Kato T, Ogami K, Shimada Y et al, Purification and characterization of thrombopoietin. J Biochem (1995) 118: 229-36.
24. Hunt P, Li YS, Nichol JL, Purification and biologic characterization of plasma-derived megakaryocyte growth and development factor. Blood (1995) 86: 540-7.
25. Hunt P, The physiologic role and therapeutic potential of the Mpl-ligand in thrombopoiesis. Stem Cells (1995) 13: 579-87.
26. Kato T, Oda A, Ingake Y et al, Thrombin cleaves human thrombopoietin: one of the proteolytic events that generates truncated forms of thrombopoietin. Proc Natl Acad Sci USA (1997) 94: 4669-74.
27. Gurney AL, Carver-Moore K, deSauvage FJ, Moore MW, Thrombocytopenia in c-mpl-deficient mice. Science (1994) 265: 1445-7.
28. Nichol JL, Hokom MM, Hornkohl A et al, Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. J Clin Invest (1995) 95: 2973-8.
29. Usuki K, Tahara T, Iki S et al, Serum thrombopoietin level in various hematological diseases. Stem Cells (1996) 14: 558-65.
30. Broudy VC, Lin NL, Sabath DF et al, Human platelets display high-affinity receptors for thrombopoietin. Blood (1997) 89: 1896-904.
31. Fielder PJ, Hass P, Nagel M et al, Human platelets as a model for the binding and degradation of thrombopoietin. Blood (1997) 89: 2782-8.
32. Fielder PJ, Gurney AL, Stefanich E et al, Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood (1996) 87: 2154-61.
33. Chang M, Suen Y, Meng G et al, Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production. Blood (1996) 88: 3354-62.
34. Shivdasani RA, Rosenblatt MF, Zucker-Franklin D et al, Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell (1995) 81: 695-704.
35. Stefanich E, Senn T, Widmer R et al, Metabolism of thrombopoietin (TPO) in vivo: determination of the binding dynamics for TPO in mice. Blood (1997) 89: 4063-70.
36. Broudy VC, Lin NL, Kaushansky K, Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood (1995) 85: 1719-26.
37. Hunt P, Li Y-S, Nichol JL et al, Purification and biologic characterization of plasma-derived megakaryocyte growth and development factor. Blood (1995) 86: 540-7.
38. Banu N, Wang JF, Deng B et al, Modulation of megakaryocytopoiesis by thrombopoietin: the c-Mpl ligand. Blood (1995) 86: 1331-8.
39. Kaushansky K, Lok S, Holly RD et al, Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature (1994) 369: 568-71.
40. Debili N, Wendling F, Katz A et al, The Mpl ligand or thrombopoietin or megakaryocyte growth and differentiation factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood (1995) 86; 2516-25.
41. Porteu F, Rouyez M-C, Cocault L et al, Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin. Mol Cell Biol (1996) 16: 2473-82.
42. Zeigler FC, deSauvage F, Widmer HR et al, In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood (1994) 84: 4045-52.
43. Choi ES, Hokom M, Bartley T et al, Recombinant human megakaryocyte growth and development factor (MGDF), a ligand for c-Mpl, produces functional human platelets in vitro. Stem Cells (1995) 13: 317-22.
44. Kuter DJ, Beeler DL, Rosenberg RD, The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci USA (1994) 91: 11 108-12.
45. Choi ES, Hokom MM, Chen J-L et al, The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis. Br J Haematol (1996) 95: 227-33.
46. Oda A, Miyakawa Y, Druker BJ et al, Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. Blood (1996) 87: 4664-70.
47. Montruccio G, Brizzi MF, Calosso G et al, Effects of recombinant human megakaryocyte growth and development factor on platelet activation. Blood (1996) 87: 2762-8.
48. Toombs CF, Young CH, Glaspy JA, Varnum BC, Megakaryocyte growth and development factor (MGDF) moderately enhances in-vitro platelet aggregation. Thromb Res (1995) 80: 23-33.
49. Vigon I, Florindo C, Fichelson S et al, Characterization of the murine Mpl proto-oncogene, a member of the hematopoietic cytokine receptor superfamily: molecular cloning, chromosomal location and evidence for a function in cell growth. Oncogene (1993) 8: 2607-15.
50. Alexander WS, Metcalf D, Dunn AR, Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J (1995) 14: 5569-78.
51. Ihle JN, Witthuhn BA, Quelle FW et al, Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol (1995) 13: 369-98.
52. Drachman JG, Griffin JD, Kaushansky K, The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc and c-Mpl. J Biol Chem (1995) 270: 4979-82.
53. Dorsch M, Fan PD, Bogenberger J, Goff SP, TPO and IL-3 induce overlapping but distinct protein tyrosine phosphorylation in a myeloid precursor cell line. Biochem Biophys Res Commun (1995) 214: 424-31.
54. Mu SX, Xia M, Elliot G et al, Megakaryocyte growth and development factor and interleukin-3 induce patterns of protein-tyrosine phosphorylation that correlate with dominant differentiation over proliferation of mpl-transfected 32D cells. Blood (1995) 86: 4532-43.
55. Pallard C, Goullineux F, Benit L et al, Thrombopoietin activates a STAT5-like factor in hematopoietic cells. EMBO J (1995) 14: 2847-56.
56. Sasaki K, Odai H, Hanazono Y et al, TPO/c-Mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products Vav and c-Cbl, and Ras signaling molecules. Biochem Biophys Res Commun (1995) 216: 338-47.
57. Ezumi Y, Takayama H, Okuma M, Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, Jak2, and STAT3, and enhances agonists-induced aggregation in platelets in vitro. FEBS Lett (1995) 374: 48-52.
58. Miyakawa Y, Oda A, Druker BJ et al, Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets. Blood (1995) 86: 23-7.
59. Alexander WS, Maurer AB, Novak U, Harrison-Smith M, Tyrosine-599 of the c-Mpl receptor is required for Shc phosphorylation and the induction of cellular differentiation. EMBO J (1996) 15: 6531-40.
60. Drachman JG, Kaushansky K, Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain. Proc Natl Acad Sci USA (1997) 94: 2350-5.
61. Miyakawa Y, Oda A, Druker BJ et al, Thrombopoietin induces tyrosine phosphorylation of STAT3 and STAT5 in human blood platelets. Blood (1996) 87: 439-46.
62. Sattler M, Durstin MA, Frank DA et al, The thrombopoietin receptor c-Mpl activates Jak2 and Tyk2 tyrosine kinases. Exp Hematol (1995) 23: 1040-8.
63. Tortolani PJ, Johnston JA, Bacon CM et al, Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase JAK2. Blood (1995) 85: 3444-51.
64. Gurney AL, Wong SC, Henzel WJ, deSauvage FJ, Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylation. Proc Natl Acad Sci USA (1995) 92: 5292-6.
65. Bacon CM, Tortolani PJ, Shimosaka A et al, Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT3 and STAT5. FEBS Lett (1995) 370: 63-8.
66. Yamashita Y, Miyazato A, Shimizu R et al, Tec protein tyrosine kinase is involved in the thrombopoietin/c-Mpl signaling pathway. Exp Hematol (1997) 25: 211-16.
67. WAF1/Cip1 by STAT5. Mol Cell Biol (1997) 17: 2933-43.
68. Alexander WS, Roberts AW, Nicola NA et al, Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mpl. Blood (1996) 87: 2162-70.
69. deSauvage FJ, Carver-Moore K, Luoh S-M et al, Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med (1996) 183: 651-6.
70. Carver-Moore K, Broxmeyer HE, Luoh S-M et al, Low levels of erythroid and myeloid progenitors in thrombopoietin and c-mpl-deficient mice. Blood (1996) 88: 803-8.
71. Kobayashi M, Laver JH, Kato T et al, Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors. Blood (1995) 86: 2494-9.
72. - primitive progenitor cells. Blood (1996) 88: 1619-31.
73. - progenitor cells cultured in serum-depleted medium. Stem Cells (1997) 15: 18-32.
74. Rasko JIJ, O'Flaherty E, Begley CG, Mpl ligand (MGDF) alone and in combination with stem cell factor (SCF) promotes proliferation and survival of human megakaryocyte, erythroid and granulocyte/macrophage progenitors. Stem Cells (1997) 15: 33-42.
75. Ku H, Yonemura Y, Kaushansky K, Ogawa M, Thrombopoietin, the ligand for the Mpl receptor, synergizes with Steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood (1996) 87: 4544-51.
76. Sitnicka E, Lin N, Priestly GV et al, The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood (1996) 87: 4998-5005.
77. Ramsfjell V, Borge OJ, Veiby OP et al, Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligand for c-kit and FLT3. Blood (1996) 88: 4481-92.
78. Nishinakamura R, Miyajima A, Mee PJ et al, Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating facror/interleukin-2/interleukin-5 functions. Blood (1996) 88: 2458-64.
79. Nandurkar HH, Robb L, Tarlinton D et al, Adult mice with targeted mutation of the interleukin-11 receptor (IL-11Ra) display normal hematopoiesis. Blood (1997) 90: 2148-59.
80. Poli V, Balena R, Fattori E et al, Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion EMBO J (1994) 13: 1189-96.
81. Peng J, Friese P, Wolf RF et al, Relative reactivity of platelets from thrombopoietin- and interleukin-6-treated dogs. Blood (1996) 87: 4158-63.
82. Farese AM, Hunt P, Boone T, MacVittie TJ, Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood (1995) 86: 54-9.
83. Harker LA, Marzec UM, Hunt P et al, Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates. Blood (1996) 88: 511-21.
84. Arnold JT, Daw NC, Stenberg PE et al, A single injection of pegylated megakaryocyte growth and development factor (MODF) into mice is sufficient to produce a profound stimulation of megakaryocyte frequency, size and ploidization. Blood (1997) 89: 823-33.
85. Kaushansky K, Lin N, Grossmann A et al, Thrombopoietin expands erythroid, granulocyte-macrophage and megakaryocytic progenitor cells in normal and myelosuppressed mice. Exp Hematol (1996) 23: 265-9.
86. Farese AM, Hunt P, Grab LB, MacVittie TJ, Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multi-lineage hematopoietic reconstitution in nonhuman primates after radiation induced marrow aplasia. J Clin Invest (1996) 97: 2145-51.
87. Grossmann A, Lenox J, Ren HP et al, Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice. Exp Hematol (1996) 24: 1238-46.
88. Ulich TR, del Castillo J, Senaldi G et al, Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice. Blood (1996) 87: 5006-15.
89. Grossmann A, Lenox J, Deisher TA et al, Synergistic effects of thrombopoietin and granulocyte colony-stimulating factor on neutrophil recovery in myelosuppressed mice. Blood (1996) 88: 3363-70.
90. Fibbe WE, Heemskerk DPM, Laterveer L et al, Accelerated reconstitution of platelets and erythrocytes following syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice. Blood (1995) 86: 3308-13.
91. Molineux G, Hartley CA, McElroy P et al, Megakaryocyte growth and development factor stimulates enhanced platelet recovery in mice after bone marrow transplantation. Blood (1996) 88: 1509-14.
92. Yan XQ, Lacey D, Fletcher F et al, Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood (1995) 86: 4025-33.
93. Yan XQ, Lacey D, Hill D et al, A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. Blood (1996) 88: 402-9.
94. Kaushansky K, Broudy VC, Grossmann A et al, Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. J Clin Invest (1995) 96: 1683-7.
95. Basser RJL, Rasko JEJ, Clarke K et al, Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. Lancet (1996) 348: 1279-81.
96. O'Malley CJ, Rasko JEJ, Basser RL et al, Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. Blood (1996) 88: 3288-98.
97. Basser RL, Rasko JEJ, Clarke K et al, Randomised, blinded, placebo-controlled phase 1 trial of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) with filgrastim after dose-intensive chemotherapy in patients with advanced cancer. Blood (1997) 89: 3118-28.
98. Rasko JEJ, Basser RL, Boyd J et al, Multilineage mobilisation of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDF. Br J Haematol (1997) 97: 871-80.
99. Franucchi M, Glasby J, Crawford J et al, Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts for chemotherapy for lung cancer. N Engl J Med (1997) 336: 404-9.
100. Vadhan-Raj S, Murray LJ, Bueso-Ramos C et al, Stimulation of megakaryocyte and platelet production of a single dose of recombinant human thrombopoietin in patients with cancer. Ann Int Med (1997) 126: 673-81.
101. Romp KG, Peters WP, Hoffman M, Reticulated platelet counts in patients undergoing autologous bone marrow transplantation: an aid in assessing marrow recovery. Am J Hematol (1994) 46: 319-24.
102. Dale GL, Friese P, Hynes LA, Burstyn SA, Demonstration that thiazole-orange-positive platelets in the dog are less than 24 hours old. Blood (1995) 85: 1822-5.
103. Wilcox GR, Berndt MC, Mehrabani PA et al, An improved method for measuring plasma glycocalicin in the investigation of causes of thrombocytopenia. Platelets (1991) 2: 45-50.
104. Beer JH, Buchi L, Steiner B, Glycocalicin: a new assay - the normal plasma levels and its potential usefulness in selected diseases. Blood (1994) 83: 691-702.
105. Metcalf D, Begley CG, Johnson GR et al, Biological properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor. Blood (1986) 67: 37-45.
106. Begley CG, Lopez AF, Nicola NA et al, Survival in vitro of mature neutrophils and eosinophils in a lineage-specific manner, a rapid sensitive microassay for colony-stimulating factors. Blood (1986) 68: 162-6.
107. Chen J, Herceg-Harjacek L, Groopman JE, Grabarek J, Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. Blood (1995) 86: 4054-62.
108. Rodriguez-Linarea B, Watson SP, Thrombopoietin potentiates activation of human platelets in association with JAK2 and TYK2 phosphorylation. Biochem J (1996) 316: 93-8.
109. Dührsen U, Villeval J-L, Boyd J et al, Effects of recombinant human granulocyte-colony stimulating factor on hematopoietic progenitor cells in cancer patients. Blood (1988) 72: 2074-81.
110. Sheridan WP, Begley CG, Juttner CA et al, Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet (1992) 339: 640-1.
111. DeLuca E, Sheridan WP, Watson D et al, Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells. Br J Cancer (1992) 66: 893-9.
112. Begley CG, Basser RL, Mansfield R et al, Enhanced levels and enhanced clonogenic capacity of blood progenitor cells following administration of SCF plus G-CSF to humans. Blood (1997) 90: 3378-89.
113. Bouscary D, Prudhomme C, Quesnel B et al, c-mpl expression in hematologic disorders. Leuk Lymphoma (1995) 17: 19-26.
114. Matsumura I, Kanakura Y, Ikeda H et al, Coexpression of thrombopoietin and c-mpl genes in acute myeloblastic leukemic cells. Leukemia (1996) 10: 91-4.
115. Quentmeier H, Zaborski M, Graf G et al, Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells. Leukemia (1996) 10: 297-310.
116. Matsumura I, Kanakura Y, Kato T et al, Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood (1995) 86: 703-9.
117. Matsumura I, Kanakura Y, Kato T et al, The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells. Blood (1996) 88: 3074-82.
118. Archimbaud E, Ottmann O, Liu Yin JA et al, A randomised, double-blind, placebo-controlled study using PEG-rHuMGDF as an adjunct to chemotherapy for adults with de-novo acute myeloid leukemia (AML): early results. Blood 88(Suppl 1): 447a (abst).